Literature DB >> 30657935

What is the prospect of a safe and effective dengue vaccine for travellers?

Anna P Durbin1, Duane J Gubler2.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 30657935     DOI： 10.1093/jtm/tay153

Source DB:  PubMed          Journal:  J Travel Med        ISSN： 1195-1982            Impact factor:   8.490


× No keyword cloud information.
  7 in total

1.  Global patterns of aegyptism without arbovirus.

Authors:  Mark F Olson; Jose G Juarez; Moritz U G Kraemer; Jane P Messina; Gabriel L Hamer
Journal:  PLoS Negl Trop Dis       Date:  2021-05-05

Review 2.  Does structurally-mature dengue virion matter in vaccine preparation in post-Dengvaxia era?

Authors:  Jedhan Ucat Galula; Gielenny M Salem; Gwong-Jen J Chang; Day-Yu Chao
Journal:  Hum Vaccin Immunother       Date:  2019-08-23       Impact factor: 3.452

3.  Imported dengue in Spain: a nationwide analysis with predictive time series analyses.

Authors:  Lidia Redondo-Bravo; Claudia Ruiz-Huerta; Diana Gomez-Barroso; María José Sierra-Moros; Agustín Benito; Zaida Herrador
Journal:  J Travel Med       Date:  2019-12-23       Impact factor: 8.490

4.  Dengue virus infections among European travellers, 2015 to 2019.

Authors:  Céline M Gossner; Nelly Fournet; Christina Frank; Beatriz Fernández-Martínez; Martina Del Manso; Joana Gomes Dias; Henriette de Valk
Journal:  Euro Surveill       Date:  2022-01

Review 5.  Dengue vaccine development: status and future.

Authors:  Annelies Wilder-Smith
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-01       Impact factor: 1.513

Review 6.  Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?

Authors:  Iris Valdés; Laura Lazo; Lisset Hermida; Gerardo Guillén; Lázaro Gil
Journal:  Front Immunol       Date:  2019-08-27       Impact factor: 7.561

Review 7.  Dengue vaccine development by the year 2020: challenges and prospects.

Authors:  Annelies Wilder-Smith
Journal:  Curr Opin Virol       Date:  2020-10-18       Impact factor: 7.090
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.